COLOMBO, DIEGO RODOLFO
COLOMBO, DIEGO RODOLFO
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
Reduction in cholesterol supply by Mecp2 null astrocytes contributes to synaptic defects
2024 F. Postogna, M. Breccia, O. Roggero, F. Biella, E. Albizzati, C. Cabasino, A. Arcari, D. Colombo, L. Morelli, E. Chiricozzi, N. Landsberger, A. Frasca
Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method
2024 M.N. Iannone, S. Valtorta, S. Stucchi, S. Altomonte, E.A. Turolla, E. Vino, P. Rainone, V. Zecca, A. Lo Dico, M. Maspero, M. Figini, M. Bellone, S. Ciceri, D. Colombo, C. Chinello, L. Pagani, R.M. Moresco, S. Todde, P. Ferraboschi
Novel Non-peptide Uracil-derived Human Gonadotropin-Releasing Hormone Receptor Antagonists
2024 S. Ciceri, E.M.A. Fassi, V. Vezzoli, M. Bonomi, D. Colombo, P. Ferraboschi, G. Grazioso, P. Grisenti, S. Villa, C. Castellano, F. Meneghetti
A new class of GnRH receptor modulators endowed with atropisomerism
2023 S. Ciceri, D. Colombo, E.M.A. Fassi, P. Ferraboschi, G. Grazioso, P. Grisenti, F. Meneghetti
Insights on the atropisomeric properties of elagolix and its derivatives
2023 S. Ciceri, D. Colombo, E.M.A. Fassi, P. Ferraboschi, G. Grazioso, P. Grisenti, F. Meneghetti
Elagolix Sodium Salt and Its Synthetic Intermediates: A Spectroscopic, Crystallographic, and Conformational Study
2023 S. Ciceri, D.R. Colombo, E.M.A. Fassi, P. Ferraboschi, G. Grazioso, P. Grisenti, M. Iannone, C. Castellano, F. Meneghetti
Antitumor Platinum(II) Hybrid Compounds Based on a Glucosylglycerol Scaffold
2023 M. Quaglia, M. Zuccolo, C. Corno, N. Carenini, P. Perego, D. Colombo
Synthesis of N-oxyamide analogues of protein kinase B (Akt) targeting anionic glycoglycerolipids and their antiproliferative activity on human ovarian carcinoma cells
2023 M. Zuccolo, G. Orsini, M. Quaglia, L. Mirra, C. Corno, N. Carenini, P. Perego, D. Colombo
The deubiquitinase USP8 regulates ovarian cancer cell response to cisplatin by suppressing apoptosis
2022 C. Corno, P. D’Arcy, M. Bagnoli, B. Paolini, M. Costantino, N. Carenini, E. Corna, P. Alberti, D. Mezzanzanica, D. Colombo, S. Linder, N. Arrighetti, P. Perego
Curcumin and Related Compounds in Cancer Cells: New Avenues for Old Molecules
2022 M. Costantino, C. Corno, D. Colombo, P. Perego
Caffeic acid phenethyl ester targets ubiquitin-specific protease 8 and synergizes with cisplatin in endometrioid ovarian carcinoma cells
2022 D. Colombo, L. Gatti, L. Sjostrand, N. Carenini, M. Costantino, E. Corna, N. Arrighetti, M. Zuccolo, M. De Cesare, S. Linder, P. D'Arcy, P. Perego
Hybrid lipid/polymer nanoparticles to tackle the cystic fibrosis mucus barrier in siRNA delivery to the lungs : does PEGylation make the difference?
2022 G. Conte, G. Costabile, D. Baldassi, V. Rondelli, R. Bassi, D. Colombo, G. Linardos, E.V. Fiscarelli, R. Sorrentino, A. Miro, F. Quaglia, P. Brocca, I. D'Angelo, O.M. Merkel, F. Ungaro
Elagolix analogues as potential new GnRH antagonists: design, synthesis and characterization
2022 S. Ciceri, D. Colombo, E. Fassi, P. Ferraboschi, G. Grazioso, P. Grisenti, F. Meneghetti
Elagolix analogues as potential new GnRH antagonists
2022 S. Ciceri, D. Colombo, E. Fassi, P. Ferraboschi, G. Grazioso, P. Grisenti, F. Meneghetti
Benzothiadiazole derivatives endowed with STAT3 inhibition
2021 A. Gelain, M. Mori, E. Gilardoni, L. Regazzoni, A. Pedretti, D. Colombo, G. Parkinson, A. Asai, F. Meneghetti, S. Villa
Design, synthesis, characterization, and biological activity of new derivatives of elagolix, a potent GnRH antagonist
2021 S. Ciceri, D.R. Colombo, P. Ferraboschi, P. Grisenti, S.V. Sforna, F. Meneghetti
An Outline of the Latest Crystallographic Studies on Inhibitor-Enzyme Complexes for the Design and Development of New Therapeutics against Tuberculosis
2021 M. Mori, S. Villa, S. Ciceri, D.R. Colombo, P. Ferraboschi, F. Meneghetti
Recent Progresses in Conjugation with Bioactive Ligands to Improve the Anticancer Activity of Platinum Compounds
2021 M. Zuccolo, N. Arrighetti, P. Perego, D.R. Colombo
Unraveling the interaction mechanism of a benzothiadiazole-2.2-dioxide derivative with STAT3 : towards novel direct inhibitors
2021 M. Mori, E. Gilardoni, L. Regazzoni, A. Pedretti, D. Colombo, G. Parkinson, A. Asai, G. Cazzaniga, F. Meneghetti, S. Villa, A. Gelain
Vecuronium bromide and its advanced intermediates : a crystallographic and spectroscopic study
2021 S. Ciceri, D. Colombo, P. Ferraboschi, P. Grisenti, M. Iannone, M. Mori, F. Meneghetti